Scott R. Shively
Founder at Neumentum, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ray Takigiku | M | - |
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 18 years |
| Joseph Pergolizzi | M | - |
Neumentum, Inc.
 Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | 7 years |
| Patrick Conners | M | - |
Moberly Natural Crush LLC
 Moberly Natural Crush LLC Agricultural Commodities/MillingProcess Industries Moberly Natural Crush LLC operates as a natural food company that will produce specialty soybean meal and oil to be sold to producers of natural food products. The company was founded by Patrick Conners and Jim Beckley in 2018 and is headquartered in Moherly, MO. | 6 years |
| Helen Hobbs | M | 71 | 13 years | |
| Jim Beckley | M | - |
Moberly Natural Crush LLC
Moberly Natural Crush LLC Agricultural Commodities/MillingProcess Industries Moberly Natural Crush LLC operates as a natural food company that will produce specialty soybean meal and oil to be sold to producers of natural food products. The company was founded by Patrick Conners and Jim Beckley in 2018 and is headquartered in Moherly, MO. | 6 years |
| Jim Beach | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Chuck Scheper | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Andrew Blank | M | 68 |
Neumentum, Inc.
Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | - |
| Catherine Pearce | F | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 1 years |
| Denis Patrick | M | - | 14 years | |
| Olivia Kirtley | F | 74 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 3 years |
| Timothy Schroeder | M | 66 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Raymond Tesi | M | 68 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | 4 years |
| Margaret M. van Gilse | F | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| Mikael Dolsten | M | 65 | 15 years | |
| Cameron Durrant | M | 63 |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
| August Moretti | M | 73 |
Neumentum, Inc.
Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | 5 years |
| Keith A Carlson | M | - |
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Bexion Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of oncology treatments. The firm is developing BXQ-350, a first-in-class agent composed of the multifunctional, lysosomal activator protein Saposin C and phosphatidylserine. The company was founded by Ray Takigiku in 2006 and is headquartered in Covington, KY. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Steere | M | 88 | 28 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| James Fogarty | M | 56 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 4 years |
| John Mascotte | M | 84 | 4 years | |
| Kurt C. Wheeler | M | 71 | 7 years | |
| Christine Mikail, | - | - |
Neumentum, Inc.
Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | - |
| Pedro Granadillo | M | 77 |
Neumentum, Inc.
Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | - |
| Christine Cvijic | F | 46 |
Neumentum, Inc.
Neumentum, Inc. Pharmaceuticals: MajorHealth Technology Neumentum, Inc. engages in the provision of pharmaceutical services. It specializes in non-opioid analgesic and neurology specialty where patient with acute and chronic pain. The company was founded by R. Scott Shively and Joseph V. Pergolizzi, Jr. on April 6, 2017 and is headquartered in Palo Alto, CA. | - |
| Marc Tessier-Lavigne | M | 64 | 4 years | |
| Robert Landry | M | 60 | 4 years | |
| Martin MacKay | M | 68 | 14 years | |
| Arda Minocherhomjee | M | 70 | 4 years | |
| James Tyree | M | 71 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | - |
| Vicente J. Anido | M | 71 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 3 years |
| Arnold R. Gammaitoni | M | 56 | 10 years | |
| Robert G. Savage | M | 70 |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | 1 years |
| Dana George Mead | M | 88 | 12 years | |
| Stephen W. Sanger | M | 78 | 9 years | |
| Freda Lewis-Hall | M | 69 | 11 years | |
| Robert N. Burt | M | 86 | 11 years | |
| Frances Fergusson | M | 79 | 9 years | |
| William R. Howell | M | 88 | 9 years | |
| Santiago Arroyo | M | 64 | 5 years | |
| Carl Morris | M | 54 | 5 years | |
| Robyn Peters | F | - | 4 years | |
| Baiyong Li | M | 56 | 12 years | |
| Karin Jooss | M | 59 | 7 years | |
| Tariq Arshad | M | 54 | 12 years | |
| William C. Kennally | M | 68 | 5 years | |
| Matthew Rossen | M | 47 | 9 years | |
| John Porter | M | 53 | 5 years | |
| Michael Williams | M | - | - | |
| Dieter Weinand | M | 63 | 3 years | |
| Glenn Miles | M | 58 | 4 years | |
| Mark Schneyer | M | 50 | 9 years | |
| Richard Burch | M | 67 | 30 years | |
| Alex Goldsmith | M | - | 7 years | |
| David Roth | M | 61 | 4 years | |
| Reina Benabou | M | 60 | 4 years | |
| Hong I. Wan | M | - | 5 years | |
| Aimee Crombie | M | - | 3 years | |
| Hua Gong | M | 57 | 10 years | |
| Paulash Mohsen | M | - | 14 years | |
| Clare Khan | M | 72 | 6 years | |
| Eva Grut-Aandahl | F | - | - | |
| Paul R. McGuirk | M | 72 | 27 years | |
| Tanya de Foras | F | 53 | 10 years | |
| Daniella Gigante | F | - | - | |
| Irina Apostolou | M | - | 5 years | |
| Ranjeev Krishana | M | 50 | 3 years | |
| Taisya Vorontsova | M | - | - | |
| Dario Paggiarino | M | 67 | 10 years | |
| Angela Rossetti | F | 71 | 5 years | |
| Paul S. Miller | M | 65 | 24 years | |
| John Henderson | M | 79 | - | |
| Adele Gulfo | F | 61 | 5 years | |
| Corey Goodman | M | 72 | 2 years | |
| Jean-Michael Halfon | M | 72 | 21 years | |
| Kim Seth | M | - | 3 years | |
| Geno Germano | M | 63 | 7 years | |
| Martine George | M | 76 | 5 years | |
| Briggs Morrison | M | 65 | 4 years | |
| Lance Berman | M | 53 | 6 years | |
| Cavan Redmond | M | 63 | 3 years | |
| James R. Thomas | M | 73 | 19 years | |
| Bradley Lerman | M | 67 | 3 years | |
| Pedro Lichtinger | M | 70 | 14 years | |
| Jennifer L. Grant | F | 52 | 3 years | |
| Brian Esser | M | - | 3 years | |
| Michael Dunne | M | 64 | 17 years | |
| David Simmons | M | 59 | 16 years | |
| Ying Song | F | - | 13 years | |
| Neil Gibson | M | 67 | 4 years | |
| David Roblin | M | 57 | 3 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Joseph Monahan | M | 69 | 7 years | |
| Alexander Fowkes | M | - | 5 years | |
| Mariano García-Valiño | M | 58 | 8 years | |
| Howard Welgus | M | 72 | 10 years | |
| Nat Ricciardi | M | 75 | 7 years | |
| Shankar Musunuri | M | 60 | 14 years | |
| Michael Loechel | M | - | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Scott R. Shively
- Personal Network
